Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Briggs wins "National Manufacturing Award 2022" at Make UK, UK's leading Manufacturer's Organization 2023-02-03 13:54
SONIRE Announces First Patient Enrolled in Randomized Phase 2 Study of Its Novel HIFU Therapy System for Unresectable Pancreatic Cancer Patients in Japan 2023-02-02 14:00
HanAll Biopharma Reports Full-Year 2022 Results and Provides Business Update 2023-02-01 20:00
CARsgen Announces Collaboration Agreement to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer 2023-01-31 21:50
Global Times: 'So much better than we had anticipated': China's rural regions embrace Spring Festival as COVID peak ebbs away 2023-01-31 21:41
Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China 2023-01-31 20:30
Appendix 4C - Q2 FY23 Quarterly Cash Flow Report 2023-01-31 20:25
Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology 2023-01-31 09:24
Help Therapeutics Announces IND Approval of First Universal iPSC-derived Cardiomyocyte Therapy for End-stage Heart Failure in China 2023-01-30 23:00
Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-TKI to Treat EGFR-mutated NSCLC Patients with CNS Metastases 2023-01-30 10:00
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results 2023-01-27 14:52
SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane 2023-01-26 14:31
iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax 2023-01-26 10:34
Singleron launches single cell eQTL analysis as part of their sequencing service 2023-01-25 19:00
CARsgen Presents Results on Anti-Claudin18.2-mAb AB011 at ASCO GI 2023-01-20 21:50
DualityBio Announces DB-1303 Granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the Treatment of Advanced, Recurrent or Metastatic Endometrial Carcinoma with HER2 Overexpression 2023-01-20 18:00
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases 2023-01-20 09:50
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS 2023-01-20 02:00
Tigermed Completes Acquisition of Marti Farm 2023-01-19 14:59
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List 2023-01-19 11:45
1 40 41 42 43 44 147